中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
22期
68-69
,共2页
功能性消化不良%生活质量%帕罗西汀
功能性消化不良%生活質量%帕囉西汀
공능성소화불량%생활질량%파라서정
Functional dyspepsia%Quality of life%Paroxetine
目的:探讨帕罗西汀对功能性消化不良(FD)患者的疗效及生活质量的影响。方法采用自身对照研究,选择符合罗马Ⅲ标准的36例FD患者,给予帕罗西汀治疗,疗程8周。FD患者的临床疗效和生活质量采用症状严重程度指数、症状频率指数、汉化版简明健康调查量表(SF-36)进行评分。结果36例均完成治疗,在治疗终点,患者的临床症状均有明显改善(P <0.01);症状的严重程度指数(9.80±1.5 vs 5.48±0.84)和频率指数(9.60±1.6 vs 5.0±0.76)均有显著降低;在治疗的第4周和第8周,FD患者在生理功能、生理职能、躯体疼痛、活力、情感职能、精神健康、社会功能和总体健康8个维度,均较治疗前改善,差异有显著性,且在治疗的第8周,改善最为明显(P<0.01)。结论帕罗西汀可以缓解FD患者临床症状,提高其生活质量。
目的:探討帕囉西汀對功能性消化不良(FD)患者的療效及生活質量的影響。方法採用自身對照研究,選擇符閤囉馬Ⅲ標準的36例FD患者,給予帕囉西汀治療,療程8週。FD患者的臨床療效和生活質量採用癥狀嚴重程度指數、癥狀頻率指數、漢化版簡明健康調查量錶(SF-36)進行評分。結果36例均完成治療,在治療終點,患者的臨床癥狀均有明顯改善(P <0.01);癥狀的嚴重程度指數(9.80±1.5 vs 5.48±0.84)和頻率指數(9.60±1.6 vs 5.0±0.76)均有顯著降低;在治療的第4週和第8週,FD患者在生理功能、生理職能、軀體疼痛、活力、情感職能、精神健康、社會功能和總體健康8箇維度,均較治療前改善,差異有顯著性,且在治療的第8週,改善最為明顯(P<0.01)。結論帕囉西汀可以緩解FD患者臨床癥狀,提高其生活質量。
목적:탐토파라서정대공능성소화불량(FD)환자적료효급생활질량적영향。방법채용자신대조연구,선택부합라마Ⅲ표준적36례FD환자,급여파라서정치료,료정8주。FD환자적림상료효화생활질량채용증상엄중정도지수、증상빈솔지수、한화판간명건강조사량표(SF-36)진행평분。결과36례균완성치료,재치료종점,환자적림상증상균유명현개선(P <0.01);증상적엄중정도지수(9.80±1.5 vs 5.48±0.84)화빈솔지수(9.60±1.6 vs 5.0±0.76)균유현저강저;재치료적제4주화제8주,FD환자재생리공능、생리직능、구체동통、활력、정감직능、정신건강、사회공능화총체건강8개유도,균교치료전개선,차이유현저성,차재치료적제8주,개선최위명현(P<0.01)。결론파라서정가이완해FD환자림상증상,제고기생활질량。
Objective To evaluate the effect of paroxetine treatment on the quality of life in patients with functional dyspepsia.Methods A self-control study on paroxetine therapy for 8 weeks in patients with functional dyspepsia according to RomeⅢcriteria was perfomerd,the clinical outcomes were evaluated by scales changes of severity index of symptom,frequency of symptom,and Chinese version of the MOS 36-iten short form healthy survey(SF-36). Results All 36 cases completed therapy,at the end of treatment,clinical symptom in all patients were improved(P < 0.01). Comprison of the scores index of symptom, quality of life of FD at the end of treatment with that at basal level,index of severity(9.80±1.5 vs 5.48 ±0.84)and frequency(9.60±1.6 vs 5.0 ±0.76) of symptoms were subsided significantly (P < 0.01),The SF-36 scores in all dimensions including physical functioning,role of physical,vitality,pain,mental health,role of emotional,social functioning and general health in patients with functional dyspepsia were significantly higher in 4 or 8 weeks after treatment respectively,the most effective mprovement in the 8 week. Conclusion Paroxetine Improves the clinical symptoms and the quality of life in FD patients.